|
63 |
Activation of interferon-signaling in chronic lymphocytic leukemia cells by the NFkB inhibitor anakinraTina YuXuan Luo1, BoYang Su3, Vincent Hung2, YuHan Luo1, Yonghong Shi2, Guizhi Wang2, and David E Spaner5
|
|
64 |
eEF2 Kinase signaling drives pancreatic tumor growth and induces protumorigenic tumor microenvironment: A Novel Molecular Target Didem Karakas
|
|
65 |
Ring Finger Protein 169 binds to the SOCS2-SH2 exosite to allosterically enhance SH2 binding to phosphorylated ligandsKunlun Li, Yuntong Wu, Ruth Cuzzupe, Laura Dagley, Colin Hockings, Grace Bidgood, Andrew Wei, Rhiannon Morris, Cyrus Tan, Farhad Dehkhoda, Narelle Keating, Edmond M Linossi, Brad Sleebs, Jeffery J Babon, Nadia J Kershaw, and Sandra E Nicholson
|
|
66 |
Proapoptotic activity of ursolic derivatives in MDA-MB-231 breast cancer cells.
Krzysztof Bielawski1, Agnieszka Gornowicz2, Wojciech Szymanowski2, Olga Michalak3, Piotr Krzeczynski3, and Anna Bielawska2
|
|
67 |
Anti-proliferative effect of novel compounds based on thiopyrano[2,3-d]thiazoles in colorectal DLD-1 carcinoma cellsRoman Lesyk1, Yuliia Kozak2, Nataliya Finiuk2, Olha Klyuchivska2, Krzysztof Bielawski3, and Anna Bielawska4
|
|
68 |
The influence of novel ursolic acid derivatives on IL-6 and TNF-α concentrations in MDA-MB-231 breast cancer cells.Anna Bielawska1, Agnieszka Gornowicz1, Olga Michalak2, Marcin Cybulski2, and Krzysztof Bielawski3
|
|
69 |
K29-linked ubiquitination of IRF9 regulates the strength of type-I interferon signalingTengfei Ren2, Wei He2, Qian Zhao2, Zhijing Zheng2, Yibo Zuo1, Yukang Yuan1, and Hui Zheng1
|
|
70 |
Medullary sinus macrophages limit cancer therapy efficacy by an efferocytosis-induced IL-33/ST2 axis in the tumor-draining lymph node.Sara Lamorte, Robbie Jin, Kitty Liu, Rene Quevedo, Luke Neufeld, Tracy McGaha, and Teresa Ciudad
|
|
71 |
Modulating the immunosuppressive pancreas tumor microenvironment through intratumoral delivery of cytokine-encoding mRNAsChaitanya Naimesh Parikh1, Kelly De Marco1, Youwei Qiao1,2, Griffin Kane3, Loretah Chibaya1, Lin Zhou1, Katherine Murphy1, Li Li2, Prabhani Atukorale3, Wen Xue2, and Marcus Ruscetti1
|
|
72 |
Use of long-acting c-type natriuretic peptide for solid tumor therapiesZhen Lu1, Ioannis Verginadis2, Motofumi Kumazoe3, Gerardo M Castillo4, Yao Yao4, Sandra Bicher2, Menghao You1, Takashi Nojiri5, Yasutake Tanaka3, Yoshinori Fujimura3, Hiroaki Onda3, Yui Hatakeyama3, Akiko Nishimoto-Ashfield4, Katrina Bykova4, Nikolay Buynov4, Hirofumi Tachibana1, Constantinos Koumenis2, Elijah Bolotin4, Serge Fuchs1, and Rebecca E Guerra4
|
|
73 |
TGF-β1 induces metastatic colonization to skeletal muscle in mouse models of metastatic breast cancerAlastair A.E Saunders1, Rachel E Thomson1, Kellie E Mouchemore2, Chris Karagiannis1, Lauren S James1, David Freestone4, Thomas B Chadwick1, Wayne Du1, Craig A Goodman1, Adam Hagg1, Hongwei Qian1, Allan D Burrows2, Thomas Gebhardt4, Robin L Anderson2, and Paul Gregorevic1
|
|
74 |
Selective ASO-based JAK2 inhibitor for the treatment of myeloproliferative disordersSandra Paulina Smieszek and Bartlomiej Przychodzen
|
|
75 |
PP2C family phosphatases regulate multiple cell death pathways induced by TNF signaling.Bogdanova Daria A1,3, Lagorgette Lisa -2, Demidov Oleg N1,2,3, and Appella Ettore -4
|
|
76 |
Immune-derived inflammation in a microbiota-dependent model of immune checkpoint inhibitor colitisSarah M Schneider1,4, Yifan Zhou1, Elizabeth M Park1,2, Laura M Kahn1,4, Morgan N Riba1,3,4, Bhakti Patel1, Josue E Pineda1,4, Meredith Klay1, Wanying Na1, and Stephanie S Watowich1,4
|
|
77 |
Limiting Macrophage Pro-Tumor Response in cancer by Targeting CTSB and non-Apoptotic Caspase-8
Emeline Kerreneur, Paul Chaintreuil, sonia Boulakirba, Guillaume Robert, Patrick Auberger, and Arnaud Jacquel
|
|
78 |
Effect of acute myeloid leukemia (AML) and cytarabine on the presence/intensity of inflammatory and anti-inflammatory cytokines in mouse testicular cells; possible regulation by granulocyte colony-stimulating factor.Mahmoud Huleihel1, Bara'ah Khaleel1, Tamar Eliahu1, Eden Arazi1, and Eitan Lunenfeld2
|
|
79 |
Potentiating CAR T cell therapy through synthetic IL-9R signalingSofia Castelli, Ugur Uslu, Amanda Finck, Mikko Siurala, Regina M Young, and Carl H June
|
|
80 |
Targeting CAIX in pancreatic cancer leads to changes in cytokine production, enhancing
anti-tumor immune responseLucia Škvarková1, Sabína Strapcová1, Mária Bartošová1, Ingeborg Režuchová1, Lucia Csáderová1,3, Olga Sedláková1, Ľubomíra Lukáčiková1, Magdaléna Barátová1, Miriam Zaťovičová1,2, Jaromír Pastorek2, and Eliška Švastová1,3
|
